石四药集团(02005)取得国家药监局有关别嘌醇片(0.1g)的药品生产注册批件

Core Viewpoint - The company, Stone Four Pharmaceutical Group, has obtained the drug production registration approval from the National Medical Products Administration of China for Allopurinol Tablets (0.1g), classified as a Class 3 chemical drug, which is considered equivalent to passing the consistency evaluation [1] Group 1 - Allopurinol Tablets are primarily used for the treatment of patients with primary or secondary gout, leukemia, lymphoma, and malignant tumors, as well as for patients with recurrent calcium oxalate stones [1]